2018
 
2015
2016
2017
2018
2019
 
2018
 


Nanjing YixinhePharmatech Co., Ltd. has passed the evaluation of Technological SMEs successfully
 
May 24th, 2018—Nanjing, China—Adhering to the "Innovation as dynamics, differentiation as core" business philosophy and being committed to providing differentiated products with intellectual property solutions and environmentally friendly chemical technology to global customers by comprehensive research and development capabilities, Nanjing F&S Pharmatech Co., Ltd.(hereinafter referred to as F&S) announced that Nanjing YixinhePharmatech Co., Ltd. (hereinafter referred to as Nanjing Yixinhe) has passed the evaluation of Science and Technology SMEs, and so did F&S before.

In 2017, the Ministry of Science and Technology, the Ministry of Finance and the State Taxation Administration establishedEvaluation Method of Technological SMEs. The Method is to promote public entrepreneurship and innovation,accelerateindustrialization of research findings,strengthenthe precise support toTechnologicalSMEs,expandtheirgroup, and cultivate new economic growth areas.

NanjingYixinhe was founded in Apr. 2016 and was co-invested 30 million Yuan by F&S and GuandongYixinPharmaceutical Co., Ltd. Facing the spring tide of the domestic healthcare reform,Nanjing Yixinheis aimed at combining the policy advantages, and commit to R&D and commercialized production of differentiated products.The company makes great efforts to provide good medicine to Chinese people more earlier.So far, Nanjing Yixinhe is the first company to start BE of Entresto in China.

About Guangdong Yixin Pharmaceutical Co., Ltd.
Founded in Feb. 2001, and headquartered in Guangzhou, Guangdong Yixin Pharmaceutical Co., Ltd. (hereinafter referred to as Guangdong Yixin) is an innovation oriented private enterprise, which integrates R&D and sales of drugs. Guangzhou Yixin has already passed the GSP certification, and has a sound sales network and mature marketing channels. The company owed two State first class drugs, the market share and the coverage rate of their products are in leading position in the like products. Guangzhou Yixin has established a highly professional brand and popularity among the domestic clinicians and patients.

About Nanjing F&S Pharmatech Co., Ltd.
Founded in Oct. 2015 and has completed two rounds of financing in January 2017 and February 2018 respectively, which is adhering to the "Innovation as dynamics, differentiation as core" business philosophy and committed to providing differentiated products with intellectual property solutions and environmentally friendly chemical technology to global customers by comprehensive research and development capabilities.

For more information of Nanjing F&S Pharmatech Co., Ltd., please visit company website www.fshpharm.com.

 
 
Copyright © 2014-2015 DEDECMS 方生和医药科技有限公司 版权所有
网站开发:希丁哥